Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA advisory committee recommends approval of Ovation's Sabril for IS and CPS

Jan. 13, 2009

Studies show GRII receptor antagonists prevent olanzapine-induced weight gain

Jan. 13, 2009

Novel mGluR2 metabotropic glutamate receptor agonists disclosed by AstraZeneca

Jan. 13, 2009

PAION's sedative CNS-7056 meets target profile in proof-of-concept study

Jan. 12, 2009

Michael J. Fox Foundation awards grant to Arcadia for development of ERbeta agonists in PD

Jan. 12, 2009

Astellas claims new N-type calcium channel blockers for alleviating pain

Jan. 12, 2009

Xenon discloses new sodium channel blockers with analgesic properties

Jan. 12, 2009

FDA issues a complete response letter for Lilly's olanzapine in schizophrenia

Jan. 9, 2009

Peptide blocking enhancer of NMDAR function suppresses pain hypersensitivity

Jan. 9, 2009

Etifoxine aids peripheral nerve recovery

Jan. 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...